Evidence map›Paper›PMID 27184991›Full record

ArticleAnnals of family medicine2016

Symptomatic and Asymptomatic Colon Cancer Recurrence: A Multicenter Cohort Study.

Laura A M Duineveld, Kristel M van Asselt, Willem A Bemelman, Anke B Smits, Pieter J Tanis, Henk C P M van Weert, Jan Wind

Abstract readMulticenter Study
In one paragraph

Article in Annals of family medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Article
  11. Article
  12. Detecting cancer recurrence in general practice: a Danish national cohort study.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  13. Review
  14. Article
  15. Clinical assessment of recurrent cancer: a Danish cohort study in general practice.The British journal of general practice : the journal of the Royal College of General Practitioners · 2026
    Article
  16. Article
  17. Article
  18. Article
  19. Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer.International journal of molecular sciences · 2025
    Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura A M DuineveldDepartment of Primary Care, Academic Medical Centre, Amsterdam, the Netherlands l.a.duineveld@amc.uva.nl.
Kristel M van AsseltDepartment of Primary Care, Academic Medical Centre, Amsterdam, the Netherlands.
Willem A BemelmanDepartment of Surgery, Academic Medical Centre, Amsterdam, the Netherlands.
Anke B SmitsDepartment of Surgery, St Antonius Hospital, Nieuwegein, the Netherlands.
Pieter J TanisDepartment of Surgery, Academic Medical Centre, Amsterdam, the Netherlands.
Henk C P M van WeertDepartment of Primary Care, Academic Medical Centre, Amsterdam, the Netherlands.
Jan WindDepartment of Primary Care, Academic Medical Centre, Amsterdam, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFollow-up after colorectal cancer treatment with curative intent aims to detect recurrences and metachronous tumors in a timely manner. The objective of this study is to assess how recurrent disease presents and is diagnosed within scheduled follow-up according to the national guideline for the Netherlands.

methodsIn a retrospective study of consecutive patients with colorectal cancer who were treated in 2 hospitals in the Netherlands, we identified patients with colon cancer who underwent surgery with curative intent between January 2007 and December 2012. Patients who developed recurrent disease were included for further analyses.

resultsFrom a total of 446 patients who were been treated for colon carcinoma with curative intent, 74 developed recurrent disease (17%). In 43 of those patients (58%), recurrent disease was detected during a scheduled follow-up visit, with 41 (95%) being asymptomatic. Tumor marker testing, imaging, and colonoscopy identified all of these recurrences. In the remaining 31 patients with recurrent disease (42%), recurrence was found during non-scheduled interval visits; 26 (84%) of these patients were symptomatic. The most prevalent symptoms were abdominal pain, altered defecation, and weight loss. Patients with asymptomatic recurrences had a significantly higher overall survival compared with patients with symptomatic recurrences.

conclusionsIn this cohort, 42% of the recurrences after initial curative treatment for colon cancer were found during non-scheduled interval visits, mainly based on symptoms. Primary care physicians who take care of patients whose colon cancer might recur should be aware of the relatively high rate of symptomatic recurrences and of typical presenting symptoms.

Indexed as

Abdominal PainAdultAgedAged, 80 and overBiomarkers, TumorCarcinomaColonic NeoplasmsColonoscopyFemaleFollow-Up StudiesHumansMaleMiddle AgedNeoplasm Recurrence, LocalNetherlandsRetrospective StudiesBiomarkers, Tumorcolon cancerfollow-uprecurrent disease

Identifiers

PMID27184991
PMCPMC4868559

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.